Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery. We empower you to screen billions of compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. No other partner understands DEL like X-Chem — our experts invented DEL-driven drug discovery and will help you leverage it with unprecedented speed and clarity. Small molecules hold exponential possibilities. Find your next candidate with X-Chem.
We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as:
-protein:protein interactions (PPI)
-antibacterial targets
-ubiquitin ligases
-epigenetic targets
-GPCRs
We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.
We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as:
-protein:protein interactions (PPI)
-antibacterial targets
-ubiquitin ligases
-epigenetic targets
-GPCRs
We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | GHO Capita... | ghocapital... |
Mentions in press and media 6
| Date | Title | Description |
| 11.06.2025 | Drug Discovery Beyond Rule of Five: ECCS Class 3 and 4 Strategies, Upcoming Webinar Hosted by Xtalks | www.x-chemrx.com In this free webinar, learn about the unique challenges and strategies for beyond rule-of-five (bRo5) drug design. Attendees will explore how in vitro assays and physicochemical properties guide bRo5 success. The featured s... |
| 14.11.2022 | Utilizing State-of-the-Art DEL Technology to Discover Compounds that Hit Challenging Therapeutic Targets, Upcoming Webinar Hosted by Xtalks | There have been many recent advances in DEL technology with the promise of helping to deliver ever more efficacious and beneficial small molecule-based tools and therapies. TORONTO (PRWEB) November 14, 2022 DNA-encoded small molecule librar... |
| 13.04.2022 | Artificial Intelligence in Drug Discovery: DEL Screening and Beyond, Upcoming Webinar Hosted by Xtalks | By utilizing DEL screening data and other proprietary chemical data sources, AI can bring the power of accurate predictive models to drug hunters. TORONTO (PRWEB) April 13, 2022 Artificial intelligence (AI) holds the promise of transforming... |
| 09.02.2022 | X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets | LONDON and HYDERABAD, India, Feb. 9, 2022 /PRNewswire/ -- A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to fi... |
| 01.11.2021 | KQ Labs data driven health accelerator announces its first exit, as Glamorous AI is acquired by X-Chem Inc | KQ Labs, a programme delivered by the Francis Crick Institute and funded by LifeArc, is proud to announce its first exit as Glamorous AI, a company that was part of KQ Labs’ third cohort, has been acquired by X-Chem, the US based global lea... |
| 13.09.2021 | The History and Development of DNA-Encoded Libraries Featuring Case Studies of Successful DEL Drug Discovery, Upcoming Webinar Hosted by Xtalks | Starting from the rise and subsequent fall of combinatorial chemistry, he will explain how this, the foundational thought experiments of Brenner and Lerner, and advances in DNA sequencing technologies, set the stage for the development of t... |